Aberdeen Group’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
735,032
+358,169
| +95% | +$6.49M | 0.02% | 532 |
|
|
2025
Q1 | $7.71M | Buy |
376,863
+197,803
| +110% | +$4.05M | 0.02% | 624 |
|
|
2024
Q4 | $4.6M | Buy |
179,060
+50,000
| +39% | +$1.29M | 0.01% | 662 |
|
|
2024
Q3 | $2.14M | Buy |
129,060
+53,060
| +70% | +$881K | ﹤0.01% | 751 |
|
|
2024
Q2 | $1.46M | Buy |
+76,000
| New | +$1.46M | ﹤0.01% | 787 |
|